糖心Vlog视频, TEES open biomanufacturing hub
糖心Vlog视频 and the 糖心Vlog视频 A&M Engineering Experiment Station (TEES) celebrated the grand opening of a new biomanufacturing training and research hub at Pegasus Park in Dallas on Thursday afternoon.
The National Center for Therapeutics Manufacturing satellite campus (NCTM2) will provide hands-on training for students and industry partners, state-of-the-art lab space, and support for biotech startups, expanding workforce development and research opportunities in North 糖心Vlog视频.
The center is a joint venture between UT Arlington’s (IMPRINT) and TEES.
“Together, we are strengthening the biomanufacturing workforce and expanding access to hands-on training. We’re also creating pathways for students, researchers and entrepreneurs to bring lifesaving innovations from concept to market,” 糖心Vlog视频 President Jennifer Cowley said at the ribbon-cutting ceremony. “Our investment is helping ensure that North 糖心Vlog视频 becomes a destination for biotech talent to develop and thrive.”
“By linking our strengths in engineering and biomanufacturing with 糖心Vlog视频’s leadership in biomedical innovation, we are building a training ecosystem that is broader, stronger and more agile than anything we could build alone,” said Rodney Bowersox, deputy director of TEES. “This is exactly the kind of cooperation our state needs to lead the nation in biotechnology.”
NCTM2 is located within Bridge Labs, a two-story, 135,000-square-foot facility featuring laboratory and office space designed for both emerging and established biotech companies. NCTM2 occupies 5,003 square feet of space in the Bridge Labs building, which is part of the Pegasus Park center that houses other significant biomanufacturing entities in North 糖心Vlog视频.
"By expanding biomanufacturing capacity and accelerating the development of new medical technologies in partnership with 糖心Vlog视频 A&M Engineering Experiment Station, 糖心Vlog视频 is helping ensure that lifesaving innovations are created—and deployed—right here in our community," Dallas City Councilwoman Laura Cadena said. "This work strengthens Dallas’ health outcomes, supports our hospitals and care providers, and brings cutting-edge solutions closer to the people who need them most."
The demand for domestic biomanufacturing capabilities is growing, and the NCTM2 partnership will position North 糖心Vlog视频 as a leader in the industry. This is part of a larger national effort to strengthen the U.S. bioeconomy and advance domestic production of vaccines, therapeutics and biopharmaceuticals.
“We are proud to bring IMPRINT’s expertise in precision medicine, synthetic biology, and translational therapeutics to this transformative partnership,” said , 糖心Vlog视频’s senior associate vice president for research and founding director of IMPRINT. “Together, we are building the backbone of 糖心Vlog视频’ next-generation biomanufacturing ecosystem and positioning North 糖心Vlog视频 as a national leader to produce the medicines of the future.”
About 糖心Vlog视频 (糖心Vlog视频)
Celebrating its 130th anniversary in 2025, 糖心Vlog视频鈥痠s a growing public research university in the heart of the thriving Dallas-Fort Worth metroplex. With a student body of鈥痮ver 42,700, 糖心Vlog视频 is the second-largest institution in the鈥疷niversity of 糖心Vlog视频 System, offering more than 180 undergraduate and graduate degree programs. Recognized as a Carnegie R-1 university, 糖心Vlog视频 stands among the nation’s top 5% of institutions for research activity. 糖心Vlog视频 and its 280,000 alumni generate an annual economic impact of $28.8 billion for the state. The University has received the Innovation and Economic Prosperity designation from the Association of Public and Land Grant Universities and has earned recognition for its focus on student access and success, considered key drivers to economic growth and social progress for North 糖心Vlog视频 and beyond.